Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia Jayer Chung, MD, David A. Timaran, MD, J. Gregory Modrall, MD, Chul Ahn, PhD, Carlos H. Timaran, MD, Melissa L. Kirkwood, MD, Mirza S. Baig, MD, R. James Valentine, MD Journal of Vascular Surgery Volume 58, Issue 4, Pages 972-980 (October 2013) DOI: 10.1016/j.jvs.2013.03.050 Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 1 Distribution of optimal management of atherosclerotic risk factors as defined by the TransAtlantic Inter-Society Consensus (TASC) II guidelines between survivors with limb salvage and decedents with/without major amputation. Journal of Vascular Surgery 2013 58, 972-980DOI: (10.1016/j.jvs.2013.03.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Fig 2 Amputation-free survival (AFS) among 98 chronic critical limb ischemia (CLI) patients stratified by optimal medical therapy at presentation. SE, Standard error. Journal of Vascular Surgery 2013 58, 972-980DOI: (10.1016/j.jvs.2013.03.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions